Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 6, 2004, Pages 607-612

  Alessandria, Carlo ^a   Gaia, Silvia ^a   Marzano, Alfredo ^a   Venon, Wilma Debernardi ^a   Fadda, Maurizio ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Functional renal failure; Model for end stage liver disease; Portal hypertension; Refractory ascites; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGE DISTRIBUTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES FLUID; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MODEL; ELECTIVE SURGERY; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; RANK SUM TEST; RECURRENT DISEASE; SCORING SYSTEM; SURVIVAL RATE; VARICOSIS;

ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2542586942     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200406000-00015     Document Type: Article

References (32)

1. Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18:273-289.
2. Ong JP, Sands M, Younossi ZM. Transjugular intrahepatic portosystemic shunt (TIPS): a decade later. J Clin Gastroenterol 2000; 30:14-28.
3. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21:709-716.
4. Michl P, Gülberg V, Bilzer M, Waggershauser T, Raiser M, Gerbes AL. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand J Gastroenterol 2000; 35:654-658.
5. Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28:416-422.
6. Brensing KA, Textore J, Perz J, Schiedermaier P, Raab P, Strunk H, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47:288-295.
7. Wong F. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome and ascites. Digestion 1998; 59 (suppl 2):41-44.
8. Jabbour N, Zajko AB, Orons PD, Irish W, Bartoli F, Marsh WJ, et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transplant Surg 1996; 2: 139-147.
9. Malinchoc M, Kamath P, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
10. Kamath P, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
11. Deschenes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999; 94:1361-1365.
12. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.
13. Russo MW, Jacques PF, Mauro M, Odell P, Brown RS Jr. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transplant 2002; 8:271-277.
14. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002; 13:155-161.
15. Wiesner RH, McDiarmid SV, Kamath PS, Malinchoc M, Kremers WK, Krom RA, et al. MELD and PELD: application of survival models to liver allocation. Liver Transplant 2001; 7:567-580.
16. Wiesner RH, Edwards EB, Kamath PS, Kim WR, Kremers WK, Freeman RB, et al. Mayo end-stage liver disease model (MELD) score predicts liver transplant waiting list mortality: implications for liver allocation policy [Abstract]. Transplantation 2001; 7 (suppl):461.
17. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end stage liver disease and Child-Turcotte Pugh score as predictors of pretransplantation disease severity, postransplantation outcome, and resource utilisation in United Network for Organ Sharing status 2A patients. Liver Transplant 2002; 8:278-284.
18. Llado L, Figueras J, Memba R, Xiol X, Baliellas C, Vazquez S, et al. Is MELD really the definitive score for liver allocation? Liver Transplant 2002;8:795-798.
19. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
20. Rimola A, Gavaler JS, Schade RR, El-Lankany S, Starzl TE, Van Theil DH. Effects of renal impairment on liver transplantation. Gastroenterology 1987; 93:148-156.
21. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59:361-365.
22. Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver kidney transplantation. Transplantation 1996; 62:1788-1793.
23. Gines P, Sort P. Pathophysiology of renal dysfunction in cirrhosis. Digestion 1998; 59 (suppl 2):11-15.
24. Ginès A, Escorsell A, Gines P, Salo J, Jemenez W, Inglada L, et al. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105:229-236.
25. Arrayo V, Jimenez W. Complications of cirrhosis. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32 (suppl 1):157-170.
26. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164-176.
27. Alessandria C, Debernardi-Venon W, Marzano A, Barletti C, Fadda M, Rizzetto M. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur J Gastroenterol Hepatol 2002; 14:1363-1368.
28. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
29. Pagliaro L. MELD: the end of Child-Pugh classification? [Review]. J Hepatol 2002; 36:141-142.
30. Cejna M, Karnel F, Gschwantler M, Pidlich J, Kreil A, Wichlas M, et al. Child-Pugh vs MELD score to predict survival after TIPS: the Vienna-experience with 349 patients over 10 years [Abstract]. J Hepatol 2002; 36 (suppl 1):40.
31. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36:494-500.
32. Deschenes M, Dufresne M-P, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999; 94:1361-1365.